Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$11.9M
3 rounds on record
Latest round
$8.4M
Venture round · Aug 2025 · 14 mo ago
Team
1-10
employees, estimated range
The money's age
Due for its next round
14 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 12, 2025 Raised a round Venture round $8.4M · SEC Form D May 28, 2025 Raised a round Venture round $1M · SEC Form D Jun 20, 2024 Raised a round Venture round $2.5M · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2025 $8.4M — SEC Form D
Venture round May 2025 $1M — SEC Form D
Venture round Jun 2024 $2.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Continuity Biosciences, LLC SEC Form D
Founders and leadersfrom filings, registers and the company's site
Ramakrishna VenugopalanExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
FocalMedicalConvertible Note $950k · 2 yr ago • Founded 2022 • 11-50 employees
Focal Medical is a clinical stage oncology company that has developed an energy-based drug delivery system for local and precise delivery…
BioSapienSeed $1.8M · 4 yr ago • 11-50 employees
BioSapien's MediChip™ delivers sustained cancer therapy directly at the tumor site while minimizing systemic exposure through localized…
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
uPATCHSeed · 23 mo ago
We offer microneedle applicators for Drug Delivery and Biosensing.
Pirouette PharmaVenture round $1.1M · 7 mo ago • Founded 2017 • 51-200 employees • 1 role
Developing user-friendly injectable therapies that make healthcare accessible to patients worldwide. Our breakthrough auto-injector…
Intact Therapeutics1-10 employees
About Us Our Approach Our Approach You could also call this heading "Our philosophy" or "Our vision." This is the place to talk about what…

Overview

Continuity Biosciences builds adaptive combination products for precision therapeutic delivery — advancing oncology, cell therapy, and chronic disease care.

People

Ramakrishna Venugopalan
Executive Officer, Director
Robert Whitehead
Director
Michael Fowler
Director
Monica Reed
Director
Allen Weiss
Director
Josephine Torrente
Director
Joseph DeSimone
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Bradenton United States
HQ
Cary United States
Regional office
Advancing new therapeutic possibilities takes collaboration.
Office: 111 James Jackson Ave #131, Cary, NC 27513
company site

Financials

Total raised
$11.9M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $8.4M Details
Venture - Series Unknown 2025 $1M Details
Venture - Series Unknown 2024 $2.5M Details